consulting
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2008 | SCHERING PLOUGH |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$10,000 | — | |
| 2008 | SMITH &NEPHEW INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | — | |
| 2008 | UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$10,000 | — | |
| 2008 | AMGEN |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$10,000 | — | |
| 2008 | ALLERGAN |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$10,000 | — | |
| 2008 | SMITH &NEPHEW INC. |
2nd Quarter (Apr 1 - June 30) Registration |
— | — | |
| 2008 | UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$10,000 | — | |
| 2008 | SCHERING PLOUGH |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$15,000 | — | |
| 2008 | RESMED |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$15,000 | — | |
| 2008 | MEDIMMUNE INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| ASSOCIATION OF COMMUNITY CANCER CENTERS | 10 | — |
| AMGEN | 9 | $160,000 |
| ALLERGAN | 9 | $150,000 |
| RESMED | 8 | $80,000 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 6 | $130,000 |
| MCKESSON HEALTH SOLUTIONS | 6 | $55,000 |
| SMITH &NEPHEW INC. | 6 | — |
| EMPI INC | 5 | $110,000 |
| SCHERING PLOUGH | 5 | $50,000 |
| MEDIMMUNE INC | 5 | — |
| TYCO HEALTHCARE GROUP LP DBA COVIDIEN | 4 | $30,000 |
| AUSTIN STADCO LLC | 3 | $100,000 |
| WYETH PHARMACEUTICALS | 2 | $60,000 |
| BIONICARE MEDICAL TECHNOLOGIES INC | 2 | $40,000 |
| AMYLIN PHARMACEUTICALS | 2 | — |
| CYTOMEDIX INC | 1 | — |
| Name | Disclosed Prior Position |
|---|---|
| GRANT BAGLEY | |
| KELLY BARNES | |
| MICHAEL BEEBE | |
| LAUREL LINDSTROM | N/A |
| MARC B SAMUELS | N/A |
| LAUREL A TODD | N/A |